Lung Non-Small Cell Squamous Carcinoma — Trials

Lung Non-Small Cell Squamous Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 9
Ph III recruiting: 1
Growth YoY: —
Industry share: 47%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05127590	RBN-2397 in Combination With Pembrolizumab in Patients With SCCL	unknown	Phase 1 / Phase 2	50	Ribon Therapeutics, Inc.INDUSTRY	4	Jul 3, 2023	clinicaltrials
NCT05207904	Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases	unknown	Phase 2	41	Sun Yat-sen UniversityOTHER	1	Jan 26, 2022	clinicaltrials